Led · Series A · Jun 2026

Pints AI builds Autothought, a platform that plugs into core systems of banks and insurers to automate underwriting, claims, and onboarding while producing a full audit trail for every AI-assisted decision. The platform flags uncertain outputs for human review and is designed to meet requirements of regulators such as the Monetary Authority of Singapore, the Reserve Bank of India, and the Hong Kong Monetary Authority. Pints AI is also developing Autothought Studio, a toolkit intended to let institutions’ engineering teams build and manage AI applications in-house. The company plans to use its $5.6 million pre-Series A raise to expand its engineering team and to build governance and audit capabilities for new regulatory environments. It is pursuing geographic expansion across Asia Pacific and the Middle East. The article did not disclose revenues, user counts, or prior funding details.

Participated · Equity · Feb 2025

HD operates HDmall, a marketplace that aggregates healthcare productized services—from health check-ups and vaccinations to surgeries—helping users find providers, compare options, and access installment payments. The platform lists over 30,000 SKUs from more than 2,500 hospitals and clinics, works with pharmaceutical partners, and serves roughly 400,000 paying customers across Thailand and Indonesia. HD reports about $100 million in annual gross transaction volume and aims to reach 5,000 healthcare providers and 600,000 patients by 2025. The company has built Jib AI, an AI chatbot trained on anonymized product, transaction, and chat-commerce data; roughly 60% of customer interactions are now handled by AI agents. Over the next 12 months HD plans to add order and refund processing, assisted checkouts, scheduling, EHR checking, medical information retrieval, and AI-powered asynchronous virtual care; over two years it plans to expand partnerships with insurers, pharma, employers, and educational institutions. HD also plans geographic expansion into Vietnam and Myanmar in addition to its existing Thailand and Indonesia operations. HD began as a marketplace for third-party healthcare and surgery services (HDmall) and is now building conversational AI tailored to the Southeast Asian healthcare customer journey. The company plans to train chatbots on its proprietary, anonymized transaction, chat, FAQ, and product catalog data gathered over years of operations. HD has worked with roughly 2,000 healthcare providers and reports that 30–40% of its transactions occur through chat commerce. Management aims to roll out a marketplace chatbot within three months and open the technology to third parties by the end of the year, creating a new SaaS revenue stream alongside marketplace commissions. The startup positions its product as vertical, domain-specific AI—“the Sierra AI of the Southeast Asian healthcare industry”—using local data as a competitive moat. During the COVID-19 period HD cut costs, and after the pandemic it moved toward profitability with roughly 2x year-on-year growth; the team accepted a moderate valuation to accelerate growth. HD operates a marketplace for outpatient services and a recently launched private-label surgery service (HDcare) that connects surgeons in private practice, cost-conscious patients, and vacant hospital operating rooms. The platform reports a supply of over 20 operating rooms across Thailand and Indonesia, potential access to more via 1,500 healthcare providers on its marketplace, and over 40 types of surgeries lined up. HD aims to scale HDcare to 200 surgeries performed per quarter by Q4 2023. The company monetizes via transaction cuts, listing fees from providers, and healthcare marketing solutions. Since its founding four years ago and based in Bangkok, HD has served around 250,000 patients and saw 7x sales growth during the pandemic, targeting 2–3x growth in the post-COVID years. HD positions itself as enabling offline medical providers with digital tools rather than competing with them.

Led · Series A · Apr 2023

Fresh Factory is a cold chain enabler and fulfillment startup in Indonesia providing decentralized cold chain storage facilities, pick-and-pack services, and last-mile deliveries. Its network spans 22 Indonesian cities and more than 40 fulfillment centers. The company serves online and brick-and-mortar retailers, including Sirclo and Danone, and emerging customers such as Eden Farm and Kin Dairy Fresh Milk. In the previous 12 months its annual gross merchandise value increased by 10 times and its clientele doubled. By the end of the year Fresh Factory plans to expand to over 100 fulfillment centers across 50 Indonesian cities. The move targets Indonesia's underdeveloped cold chain logistics market, which faces higher setup and operating costs than customary logistics operations. Fresh Factory operates a network of hyperlocal cold storage smart warehouses and a fulfillment management system that stores, picks, packs, and delivers perishable goods for businesses. Its platform integrates GeoTagging and GeoLocation for storage, AI to forecast and manage stock, and IoT to monitor freezer and chiller temperatures. The company targets gaps in Indonesia's cold chain by placing mid- and last-mile infrastructure closer to customers across Java, Sumatra, Sulawesi, and Bali. Fresh Factory currently operates more than 20 warehouses and serves frozen-to-chilled storage needs for merchants, including SMEs and e-commerce grocers. It plans to expand warehouses to all secondary cities in Java and main cities in Sumatra and Sulawesi while investing in talent and technology to boost adoption and operational excellence. As of April 2022 the company reported roughly $10 million of annualized GMV, annualized fulfillment for more than 1 million orders, and 30% month-over-month revenue growth over the prior three months.

Participated · Series C · Sep 2021

Mfine is a digital healthcare platform providing online consultations with specialists and partnering with hospitals, clinics, diagnostics and radiology providers. Founded in 2017 by Ashutosh Lawania and Prasad Kompalli, the company is operated by Novocura Tech Health Services and is based in Bengaluru. Mfine is merging with the diagnostics business of LifeCell to form a combined entity called LifeWell. The merged business plans to build a large-scale healthcare delivery platform with full-stack diagnostics and has strategic investments and acquisitions planned to drive growth. The combined user base of Mfine and LifeCell’s diagnostics business is more than 6 million and is growing 100% year-on-year; LifeWell aims to serve over 50 million users within four years. The article notes Mfine recently carried out staff layoffs and previously raised a $48 million Series C in September last year. MFine is an AI-driven, on-demand healthcare platform that provides virtual consultations, connected care programs, diagnostic bookings, medicine delivery and in-patient procedure coordination through partnerships with leading hospitals. The platform connects users to more than 6,000 doctors from over 700 hospitals across 35 specialties, reaches over 1,000 towns, and provides access to 700 diagnostic centres in 400 cities. Since inception the company has served over 3 million users and records roughly 300,000 monthly transactions, including over 100,000 monthly diagnostic bookings. MFine says it is growing 15% month-on-month and has seen strong adoption of its corporate subscription product, which now covers over 500 corporates and 500,000 employees. Product development centers on AI clinical decision support and smartphone vitals monitoring—its SPO2 app feature has been used by 250,000 users—and the company plans to extend monitoring to heart rate and blood pressure. The company intends to invest in expanding its hospital, diagnostics and e-pharmacy networks and to roll out tech-driven care delivery and insurance-linked financial solutions. Mfine operates a digital healthcare platform that extends partner hospitals and clinics online, offering telemedicine consultations, medicine delivery and an AI-powered “virtual doctor” for report summarization, symptom narrowing and care advice. The company works with more than 500 doctors from about 100 top hospitals and claims to have enabled over 100,000 consultations across 800 towns in the past 15 months, currently running roughly 20,000 consultations per month. Mfine’s revenue model is taking a cut of consumer spending as a digital extension of its healthcare partners and it says the service can boost GP productivity 3–4X while increasing hospital revenue. The startup is pursuing corporate clients and an insurance-style subscription service, which it expects to account for around half of revenue over the coming years. Near-term operational plans include expanding offline work beyond its current markets of Hyderabad and Bangalore. The company was started in 2017 by four co-founders from Myntra. Mfine operates an online consultation app that connects patients with a network of partner hospitals and enables consultations via a chat window. The platform also supports home sample collection for lab tests and medicine ordering. Mfine says its AI engine will provide a proactive care experience and help providers engage patients in long-term care programmes. The app was expected to go live in September and the company plans to focus on Bengaluru initially before expanding to other cities. The team includes founders Prasad Kompalli and Ashutosh Lawania, former Myntra executives Ajit Narayanan and Arjun Chaudhary, and clinical advisor Dr Jagadish Prasad; the company had a 15-member team. Mfine will use the new funding for product development and working capital.